MILESTONE PHARMACEUTICALS IN (MIST) Stock Analyst Earnings Estimates
NASDAQ:MIST - Nasdaq - CA59935V1076 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 15M | 5M -66.67% | 1M -80.00% | -100.00% | 17.697M | 56.151M 217.29% | 110.42M 96.65% | 187.43M 69.74% | 248.01M 32.32% | 195.02M -21.37% | 448.6M 130.03% | ||
| EBITDA YoY % growth | -42.98M 15.08% | -59.55M -38.55% | -61.006M -2.45% | -38.76M 31.16% | -20.4M 51.43% | -61.914M -203.50% | -58.854M 4.94% | -13.158M 77.64% | 65.586M 598.45% | 158.3M 141.36% | N/A | N/A | |
| EBIT YoY % growth | -43.07M 15.07% | -59.64M -38.47% | -61.098M -2.44% | -41.018M 31.09% | -62.976M -49.58% | -73.038M -15.98% | -51.51M 29.47% | 1.275M 102.48% | 52.836M 4,044.00% | 110.16M 108.49% | 109.65M -0.46% | N/A | |
| Operating Margin | -287.13% | -1,192.80% | -6,109.80% | N/A | N/A | -412.71% | -91.73% | 1.15% | 28.19% | 44.42% | 56.23% | N/A | |
| EPS YoY % growth | -1.02 41.04% | -1.37 -34.31% | -1.39 -1.46% | -0.63 50.43% | -0.83 -20.90% | -0.87 -4.90% | -0.51 41.63% | -0.05 91.00% | 0.47 1,122.22% | 1.03 118.48% | 1.36 32.34% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 -29.32% | -0.17 -18.39% | -0.18 9.45% | -0.31 1.29% |
| Revenue Q2Q % growth | 714K | |||
| EBITDA Q2Q % growth | -5.1M 46.92% | -19.992M -109.63% | -21.318M -74.12% | N/A |
| EBIT Q2Q % growth | -12.223M -26.51% | -13.481M -40.19% | -11.764M 4.73% | -19.89M 3.08% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.31 -47.62% | -0.19 | -0.12 | -64.28% |
| Q4 2024 Q2Q % growth | -0.20 37.81% | -0.16 | -0.04 | -27.93% |
| Q3 2024 Q2Q % growth | -0.14 60.00% | -0.17 | 0.03 | 15.96% |
| Q2 2024 Q2Q % growth | -0.14 62.16% | -0.19 | 0.05 | 27.76% |
| Q1 2024 Q2Q % growth | -0.21 40.00% | -0.27 | 0.06 | 20.81% |
| Q4 2023 Q2Q % growth | -0.32 -3.23% | -0.32 | 0.00 | -0.39% |
| Q3 2023 Q2Q % growth | -0.35 -2.94% | -0.39 | 0.04 | 10.17% |
| Q2 2023 Q2Q % growth | -0.37 5.13% | -0.39 | 0.02 | 6.02% |
| Q1 2023 Q2Q % growth | -0.35 -6.06% | -0.41 | 0.06 | 13.78% |
| Q4 2022 Q2Q % growth | -0.31 22.50% | -0.34 | 0.03 | 9.28% |
| Q3 2022 Q2Q % growth | -0.34 | -0.42 | 0.08 | 18.30% |
| Q2 2022 Q2Q % growth | -0.39 -2,050.00% | -0.37 | -0.02 | -6.21% |
| Q1 2022 Q2Q % growth | -0.33 -10.00% | -0.40 | 0.07 | 17.04% |
| Q4 2021 Q2Q % growth | -0.40 -207.69% | -0.37 | -0.03 | -7.74% |
| Q3 2021 Q2Q % growth | -0.34 15.00% | -0.39 | 0.05 | 13.19% |
| Q2 2021 Q2Q % growth | 0.02 103.77% | -0.27 | 0.29 | 107.48% |
| Q1 2021 Q2Q % growth | -0.30 55.22% | -0.33 | 0.03 | 10.33% |
| Q4 2020 Q2Q % growth | -0.13 79.37% | -0.41 | 0.28 | 68.61% |
| Q3 2020 Q2Q % growth | -0.40 23.08% | -0.50 | 0.10 | 19.97% |
| Q2 2020 Q2Q % growth | -0.53 49.04% | -0.48 | -0.05 | -11.15% |
| Q1 2020 Q2Q % growth | -0.67 | -0.76 | 0.09 | 11.53% |
| Q4 2019 Q2Q % growth | -0.63 | -0.53 | -0.10 | -19.93% |
| Q3 2019 Q2Q % growth | -0.52 | -0.49 | -0.03 | -5.11% |
| Q2 2019 Q2Q % growth | -1.04 | -0.48 | -0.56 | -114.65% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 3.5M | 892.5K | 2.608M | 292.16% |
| Q2 2022 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | 15M | 3.06M | 11.94M | 390.20% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.39% | 15.48% | 0% | 14.26% |
| Revenue | N/A | N/A | N/A | N/A |